Table 1.

Patient characteristics and findings

Case #	Gender	Age	Diagnosis	Clinical status*	IDH1 status	[2HG] (ng/ml)—LC–MS	2HG/Cr ratio—MRS
2117	Female	22	Anaplastic astrocytoma, WHO grade III	ND	R132C	48700	1.044
2128	Male	61	Anaplastic oligoastrocytoma, WHO grade III	Rec.	R132H	166000	1.424
2140	Female	67	Anaplastic oligodendroglioma, WHO grade III	ND	R132H	58700	1.494
2147	Male	30	Anaplastic astrocytoma, WHO grade III	Rec.	R132H	64350	0.358
2153	Male	38	Oligoastrocytoma, WHO grade II	Rec.	R132H	13500	0.146
2155	Male	66	Anaplastic astrocytoma, WHO grade III	Rec.	R132H	58400	N/A
2160	Male	55	Anaplastic oligodendroglioma, WHO grade III	ND	R132H	148500	1.368
2166	Female	36	Anaplastic oligoastrocytoma, WHO grade III	Rec.	R132C	179000	0.810
2169	Male	41	Anaplastic oligodendroglioma WHO grade III	ND	R132H	117500	0.882
2199	Female	41	Oligoastrocytoma (WHO grade III)	Rec.	R132H	50200	0.330
2132	Male	62	Glioblastoma, WHO grade IV	ND	WT	2330	0.089
2133	Male	66	Glioblastoma, WHO grade IV	Rec.	WT	990.5	0
2139	Male	40	Glioblastoma, WHO grade IV	Rec.	WT	3860	0
2145	Male	85	Glioblastoma, WHO grade IV	ND	WT	2880	N/A
2146	Male	57	Anaplastic astrocytoma, WHO grade III	ND	WT	460	0
2149	Female	87	Glioblastoma, WHO grade IV	ND	WT	739.5	0
2163	Male	76	Glioblastoma, WHO grade IV	Rec.	WT	2630	N/A
2164	Female	63	Glioblastoma, WHO grade IV	Rec.	WT	175.5	0
2165	Female	44	Glioblastoma, WHO grade IV	ND	WT	1135	0
2172	Female	65	Glioblastoma, WHO grade IV	ND	WT	789	0.793
2173	Female	55	Glioblastoma, WHO grade IV	Rec.	WT	1540	0.047
2179	Female	60	Glioblastoma, WHO grade IV	Rec.	WT	340	0.509
2182	Female	66	Glioblastoma, WHO grade IV	Rec.	WT	631	0.412
2183	Female	45	Glioblastoma, WHO grade IV	ND	WT	787	0.030
2191	Male	56	Glioblastoma, WHO grade IV	Rec.	WT	853	0
2195	Male	59	Glioblastoma, WHO grade IV	ND	WT	403	0.424
2201	Male	63	Glioblastoma, WHO grade IV	Rec.	WT	4500	0

^*ND newly diagnosed; Rec. recurrent